Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health

• First-quarter 2024 sales of $2.4 billion, up 5%, or 7% constant currency¹ (cc)
• First-quarter 2024 diluted EPS of $0.50, up 43%, or 62% cc; core diluted EPS² of $0.78 up 11%, or 21% cc
• First-quarter 2024 cash from operations of $341 million; free cash flow³ of $229 million, up $248 million year-over year
• Dividend of CHF 0.24 per share approved by shareholders at the Annual General Meeting on May 8, 2024

Ad Hoc Announcement Pursuant to Art. 53 LR

GENEVA–(BUSINESS WIRE)–Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ended March 31, 2024. For the first quarter of 2024, sales were $2.4 billion, an increase of 5% on a reported basis and 7% on a constant currency basis¹, as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.50 and core diluted earnings per share² of $0.78 in the first quarter of 2024.